ArticleOpen forum infectious diseases2022

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection.

Nina Ekström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.